<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">91502</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Glyukokortikoidnyy osteoporoz: sovremennye rekomendatsii</article-title><trans-title-group xml:lang="ru"><trans-title>Глюкокортикоидный остеопороз: современные рекомендации</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nasonov</surname><given-names>E. L</given-names></name><name xml:lang="ru"><surname>Насонов</surname><given-names>Е. Л</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ГУ Институт ревматологии РАМН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2002-08-15" publication-format="electronic"><day>15</day><month>08</month><year>2002</year></pub-date><volume>4</volume><issue>8</issue><issue-title xml:lang="en">VOL 4, NO8 (2002)</issue-title><issue-title xml:lang="ru">ТОМ 4, №8 (2002)</issue-title><fpage>403</fpage><lpage>408</lpage><history><date date-type="received" iso-8601-date="2021-12-28"><day>28</day><month>12</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2002, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2002, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2002</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/91502">https://consilium.orscience.ru/2075-1753/article/view/91502</self-uri><abstract xml:lang="ru"><p>В настоящее время глюкортикоиды (ГК) относятся к числу наиболее широко применяемых в медицине лекарственных средств. Нарушение метаболизма костной ткани, ведущее к развитию остеопороза и переломов костей скелета, - наиболее частый побочный эффект лечения супрафизиологическими дозами ГК. ГКО - вторая (после постменопаузального) наиболее частая форма остеопороза и самая частая форма вторичного остеопороза, связанного с приемом лекарственных препаратов Лечение кальцием и витамином D (или альфакальцилом) показано всем пациентам, которым планируется длительная ГК-терапия. Однако у пациентов, вынужденных в течении длительного времени принимать средние или высокие дозы ГК, необходимо незамедлительное назначение антирезорбтивных препаратов. Мы надеемся, что внедрение данных рекомендаций будет способствовать расширению знаний о ГКО, а следовательно, оказанию более эффективной помощи пациентам, страдающим различными заболеваниям внутренних органов.</p></abstract></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Насонов Е.Л., Скрипникова И.А., Насонова В.А. Проблема остеопороза в ревматологии. М.: СТИН.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Saag K, Koehnke R, Caldwell J, Brasington R. et al. Am J Med 1994; 96: 115-23.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Van Staa T.P, Leufkens H.G, Abenhaim L.et al. J Bone Miner Res 2000; 15: 993-1000.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Van Staa T.P, Leufkens H.G, Abenhaim L. et al. Rheumatology (Oxford) 2000; 39: 1383-9.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Walsh L.J, Wong C.A, Pringle M, Tattersfield A.E. BMJ 1996; 313: 344-6.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Van Staa T.P, Leufkens G.H, Abenhaim L. et al. QJM 2000; 93: 105-11.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Buckley L.M, Marquez M, Hudson J. et al. J Rheumatol 1998; 25: 2195-202..</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Soucy E, Bellamy N, Adachi J.D. et al. J Rheumatol 2000; 27: 1506-12.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Michel B.A, Bloch D.A, Wolfe F, Fries J.F. J Rheumatol 1993; 20: 1666-9.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>American College of Rheumatology ad Hoc committee on glucocorticoid - induced osteoporosis. Recommendation for the prevention of glucocorticoid - induced osteoporosis. Arthritis Rheum 2001; 44: 1496-503.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Amin S, La Valley M.P, Simms R.W, Felson D.T. Arthritis Rheum 1999; 42: 1740-51.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Homik J, Suarez-Almazor M.E, Shea B. et al. In.: The Cochrane Library. Issue 2. Oxford (UK): Update Software; 2000.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Homik J, Cranney A, Shea B. et al. In.: The Cochrane Library. Issue 2. Oxford (UK): Update Software; 2000.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Cranney A, Welch V, Adachi J.D. et al. In.: The Cochrane Library. Issue 2. Oxford (UK): Update Software; 2000.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Buckley L.M, Leib E.S, Cartularo K.S. et al. Ann Intern Med 1996; 125: 961-86.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Saag K.G, Emkey R, Schnitzer T.J. et al. N Engl J Med 1998; 339: 292.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Reid D.M, Hughes R.A, Laan R.F. et al. J Bone Miner Res 2000; 15: 1006-20.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Reginster J.Y, Kuntz D, Verdickt W. et al. Osteoporos Int 1999; 9: 75-81.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Buckley L.M, Hillner B. Arthritis Rheum 1997; 40 Suppl. 9: S136.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Cohen S, Levy R.M, Keller M. et al. Arthritis Rheum 1999; 42: 2309-18.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Manolagas S.C, Weinstein R.S. J Bone Miner Res 1999; 14: 1061-6.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Canalis E. Curr Opin Endocrinol Diabetes 2000; 7: 320-4.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Weinstein R.S. Clin Exp Rheumatol 2000; 18 Suppl 21: S35-40.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Reid I.R, Wattie D.J, Evans M.C, Stapleton J.P. Arch Intern Med 1996; 156: 1173-7.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Adachi J.D, Saag K.G, Delmas P.D. et al. Arthritis Rheum 2001; 44: 202-11.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Wallach S, Cohen S, Reid D.M. et al. Calcif Tissue Int 2000; 67: 277-85.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Sambrook P.N. J Bone Miner Res 2000; 15: 1645-9.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Plotkin L.I, Weinstein R.S, Parfitt A.M. et al. J Clin Invest 1999; 104: 1363-74.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Kotaniemi A, Piirainen H, Paimela L. et al. J Rheumatol 1996; 23: 1875-9.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Healey J.H, Paget S.A, Williams-Russo P. et al. Calcif Tissue Int 1996; 58: 73-80.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Adachi J.D, Bensen W.G, Bell M.J. et al. Br J Rheumatol 1997; 36: 255-9.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Ringe J.D, Welzel D. Eur J Clin Pharmacol 1987; 33: 35-9.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Luengo M, Picado C, Del Rio L. et al. Am Rev Respir Dis 1990; 142: 104-7.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Luengo M, Pons F, Martinez de Osaba J.M, Picado C. Thorax 1994; 49: 1099-102.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Lems W.F, Jacobs W.G, Bijlsma J.W. et al. Osteoporos Int 1997; 7: 575-82.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Lems W.F, Jacobs J.W, Bijlsma J.W. et al. Ann Rheum Dis 1997; 56: 357-63.</mixed-citation></ref></ref-list></back></article>
